No Seroconversion for Anti-Β2GPI Antibodies in Patients Treated With Prometic’s Intravenous Immunoglobulin 10% Solution

Journal of Allergy and Clinical Immunology - United States
doi 10.1016/j.jaci.2018.12.345
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Immunoglobulin G Fc N-Glycosylation in Guillain-Barré Syndrome Treated With Intravenous Immunoglobulin

Clinical and Experimental Immunology
AllergyImmunology
2014English

AB1031 Anti-Drug Antibodies: Assay Performance in Patients Treated With ANTI-TNF Biodrugs

2017English

Opsonic Activity in Serum From Septic Infants Treated With Intravenous Immunoglobulin.

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
1989English

Recalcitrant, Delayed Pressure Urticaria Treated With Long-Term Intravenous Immunoglobulin

JAAD Case Reports
Dermatology
2020English

Anti-Blood Group Antibodies in Intravenous Immunoglobulin May Complicate Interpretation of Antibody Titers in ABO-Incompatible Transplantation

American Journal of Transplantation
TransplantationAllergyImmunologyPharmacology
2016English

Hemolysis From Intravenous Immunoglobulin in Obese Patients With Kawasaki Disease

Frontiers in Pediatrics
Child HealthPediatricsPerinatology
2020English

Anti-Drug Antibodies in Colombian Patients With Rheumatoid Arthritis Treated With Enbrel vs Etanar – Preliminary Report

Journal of Immunotoxicology
ToxicologyImmunology
2017English

Anti-Thyroid Antibodies in Patients With Hyperprolactinemia.

Endocrinologia Japonica
1991English

Lamotrigine-Induced Toxic Epidermal Necrolysis Treated With Intravenous Immunoglobulin and Amniotic Membranes

Archives of Dermatology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy